These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27311104)

  • 1. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT).
    Shahin O; Gohar SM; Ibrahim W; El-Makawi SM; Fakher W; Taher DB; Abdel Samie M; Khalil MA; Saleh AA
    Int J Psychiatry Clin Pract; 2022 Nov; 26(4):370-375. PubMed ID: 35192426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
    Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
    J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum levels of brain-derived neurotrophic factor with electroconvulsive therapy and pharmacotherapy and its clinical correlates in male schizophrenia patients.
    Akbas I; Balaban OD
    Acta Neuropsychiatr; 2022 Apr; 34(2):99-105. PubMed ID: 34924073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
    Chiou YJ; Huang TL
    World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
    Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
    J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia.
    Li J; Zhang X; Tang X; Xiao W; Ye F; Sha W; Jia Q
    Schizophr Res; 2020 Apr; 218():295-297. PubMed ID: 31932174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia-A Systematic Review and Meta-Analysis.
    Szota AM; Kowalewska B; Ćwiklińska-Jurkowska M; Dróżdż W
    J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effectiveness of rehabilitation of people diagnosed with schizophrenia using clinical tools, psychological tests, QEEG, and the brain-derived neurotrophic factor (BDNF).
    Markiewcz RA; Markiewicz-Gospodarek A; Kozioł M; Szulecka B; Olajossy M; Plech T
    Psychiatr Pol; 2019 Dec; 53(6):1275-1292. PubMed ID: 32017817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter.
    Wang J; Tang Y; Curtin A; Xia M; Tang X; Zhao Y; Li Y; Qian Z; Sheng J; Zhang T; Jia Y; Li C; Wang J
    Brain Stimul; 2019; 12(2):319-328. PubMed ID: 30473477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
    Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H
    Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
    Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
    Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
    Kranaster L; Hellweg R; Sartorius A
    Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.